These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 37596566)

  • 1. Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study.
    Bi Y; Zhu Y; Tang S; Huang Y
    J Headache Pain; 2023 Aug; 24(1):112. PubMed ID: 37596566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study.
    Cai G; Liu J; Cai M; Shao L
    Lipids Health Dis; 2024 Aug; 23(1):237. PubMed ID: 39090671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic insights into the association of statin and newer nonstatin drug target genes with human longevity: a Mendelian randomization analysis.
    Chen H; Zhou X; Hu J; Li S; Wang Z; Zhu T; Cheng H; Zhang G
    Lipids Health Dis; 2023 Dec; 22(1):220. PubMed ID: 38082436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of genetically predicted lipid traits and lipid-modifying targets with heart failure.
    Xiao J; Ji J; Zhang N; Yang X; Chen K; Chen L; Huang W
    Eur J Prev Cardiol; 2023 Mar; 30(4):358-366. PubMed ID: 36520639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic association of lipid-lowering drugs with aortic aneurysms: a Mendelian randomization study.
    Gao X; Luo W; Qu L; Yang M; Chen S; Lei L; Yan S; Liang H; Zhang X; Xiao M; Liao Y; Lee AP; Zhou Z; Chen J; Zhang Q; Wang Y; Xiu J
    Eur J Prev Cardiol; 2024 Jul; 31(9):1132-1140. PubMed ID: 38302118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mendelian randomization study of lipid metabolism characteristics and migraine risk.
    Hong P; Han L; Wan Y
    Eur J Pain; 2024 Jul; 28(6):978-986. PubMed ID: 38183343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids, lipid-modified drug target genes, and the risk of male infertility: a Mendelian randomization study.
    Li W; Li H; Zha C; Che B; Yu Y; Yang J; Li T
    Front Endocrinol (Lausanne); 2024; 15():1392533. PubMed ID: 39114294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential association of genetically predicted lipid and lipid-modifying drugs with rheumatoid arthritis: A Mendelian randomization study.
    Huang Z; Cui T; Yao J; Wu Y; Zhu J; Yang X; Cui L; Zhou H
    PLoS One; 2024; 19(2):e0298629. PubMed ID: 38416767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study.
    Gormley M; Yarmolinsky J; Dudding T; Burrows K; Martin RM; Thomas S; Tyrrell J; Brennan P; Pring M; Boccia S; Olshan AF; Diergaarde B; Hung RJ; Liu G; Legge D; Tajara EH; Severino P; Lacko M; Ness AR; Davey Smith G; Vincent EE; Richmond RC
    PLoS Genet; 2021 Apr; 17(4):e1009525. PubMed ID: 33886544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between lipid-lowering agents with intervertebral disc degeneration, sciatica and low back pain: a drug-targeted mendelian randomized study and cross-sectional observation.
    Liu C; Chu X; Biao Y; Jin Q; Zhang Y; Gao Y; Feng S; Ma J; Zhang Y
    Lipids Health Dis; 2024 Oct; 23(1):327. PubMed ID: 39358768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Lipids and Lipid-Lowering Drugs with Risk of Vascular Dementia: A Mendelian Randomization Study.
    Zhang X; Geng T; Li N; Wu L; Wang Y; Zheng D; Guo B; Wang B
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing lipid-lowering drugs on asthma and lung function: evidence from a genetic association analysis.
    Zhang Y; Jiang Z; Chen L; Lei T; Zheng X
    J Transl Med; 2024 Jul; 22(1):615. PubMed ID: 38961500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study.
    Qiao L; Lv S; Meng K; Yang J
    Clin Rheumatol; 2024 Mar; 43(3):939-947. PubMed ID: 38198113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
    Richardson TG; Leyden GM; Wang Q; Bell JA; Elsworth B; Davey Smith G; Holmes MV
    PLoS Biol; 2022 Feb; 20(2):e3001547. PubMed ID: 35213538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causal effects of lipid-lowering therapies on aging-related outcomes and risk of cancers: a drug-target Mendelian randomization study.
    Chen H; Tang X; Su W; Li S; Yang R; Cheng H; Zhang G; Zhou X
    Aging (Albany NY); 2023 Dec; 15(24):15228-15242. PubMed ID: 38127052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causal Relationships between Lipid-Lowering Drug Target and Aortic Disease and Calcific Aortic Valve Stenosis: A Two-Sample Mendelian Randomization.
    Yang L; Xu M; Gao X; Liu J; Zhang D; Zhang Z; Ye Z; Wen J; Liu P
    Rev Cardiovasc Med; 2024 Aug; 25(8):292. PubMed ID: 39228495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid traits and lipid-lowering drug target genes and risk of melanoma: a mendelian randomization study.
    Che Y; Yuan J; Tang D; Guo J
    Arch Dermatol Res; 2024 May; 316(6):301. PubMed ID: 38819656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.
    Huang W; Xiao J; Ji J; Chen L
    Elife; 2021 Dec; 10():. PubMed ID: 34866576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study.
    Tan Z; Hong J; Sun A; Ding M; Shen J
    Front Endocrinol (Lausanne); 2023; 14():1301163. PubMed ID: 38107516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causal effects of circulating lipids and lipid-lowering drugs on the risk of epilepsy: a two-sample Mendelian randomization study.
    Liang Z; Zhao L; Lou Y; Liu S
    QJM; 2023 Jun; 116(6):421-428. PubMed ID: 36964718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.